Arcturus Therapeutics Holdings Inc. — Form 8-K Summary
Reporting date: September 16, 2019. This Form 8-K reports a corporate governance event under Item 8.01 and does not provide financial results for a reporting period.
Business Context and Event
The company established Friday, October 25, 2019 as the date of its 2019 Annual Meeting of Stockholders. The meeting will be held more than 30 days after the August 24, 2018 annual meeting, triggering disclosure requirements under Rule 14a-5(f) of the Exchange Act.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other financial metrics.
Material Changes
- The 2019 annual meeting date was set for October 25, 2019, compared with the August 24, 2018 annual meeting date.
- The new deadline for stockholder proposals under Rule 14a-8 to be included in the company’s proxy materials is the close of business on September 26, 2019.
- The record date for determining stockholders entitled to notice of and to vote at the meeting is the close of business on September 18, 2019.
Outlook, Risks, and Unusual Items
The filing contains no operating outlook or management discussion of business risks. Stockholder proposals must comply with SEC rules and the company’s bylaws and may be omitted if they do not satisfy applicable requirements.
Facts Investors Should Verify
- Whether the October 25, 2019 annual meeting occurred as scheduled.
- The final proxy materials, meeting agenda, and voting results.
- Whether any stockholder proposals were submitted by the September 26, 2019 deadline.
- The record-date eligibility requirements for voting at the annual meeting.